VTVT
vTv Therapeutics Inc
30.10$
-3.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -26.2% | +391.8% | -14.3% | -7.1% | -11.3% | -16.3% | -17.4% | +276.2% | -9.6% | +9.9% | -11.4% | |
| – | +5.3% | +405.5% | -14.2% | -7.0% | -11.3% | -16.3% | -17.4% | +277.1% | -9.6% | +9.9% | -11.4% | |
| – | +14.7% | +453.2% | -12.9% | -8.7% | -11.6% | -15.5% | -16.5% | +280.0% | -9.7% | +10.3% | -11.7% | |
| – | +14.7% | +453.2% | -12.9% | -8.7% | -11.6% | -15.5% | -16.5% | +280.0% | -9.7% | +10.3% | -11.7% | |
| – | – | +861.8% | -68.8% | -20.9% | -74.4% | – | – | – | – | – | – | |
| – | – | – | -6,500,100.0% | – | – | – | – | – | – | – | – | |
| – | +0.4% | -4.6% | -7.7% | -3.0% | -5.1% | -3.5% | +3.9% | +20.4% | -12.1% | -65.2% | +1.2% | |
| – | +3.3% | -16.0% | -21.7% | -8.0% | -19.1% | -16.9% | +22.7% | +91.9% | -34.7% | +3.6% | +2.0% | |
| – | -43.6% | -51.9% | +2.3% | +2.3% | -6.6% | -26.0% | -36.8% | +355.7% | – | – | – | |
| – | – | +114.3% | -22.2% | -8.3% | -84.9% | +346.3% | +24.5% | +87.9% | -88.5% | +502.6% | +2.5% | |
| – | – | – | -20.8% | -8.9% | -18.7% | -35.1% | -65.1% | +2,454.1% | -8.7% | +39.6% | -12.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.4% | +98.6% | +54.6% | -14.8% | +5.8% | +14.1% | +0.1% | +22.3% | +4.6% | +0.0% | +47.3% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.